Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Tandem Diabetes Care, Inc. (TNDM) is a Medical - Devices company based in US with a market capitalization of $1.2B. Revenue grew 7.9% year-over-year and free cash flow was negative at -$29.7M. This page tracks TNDM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.65K employees · IPO Nov 14, 2013

Valuation

Valuation & price

$12.82as of May 17, 2026· -54.6% vs 52w high

P/E ratio

Latest-FY diluted EPS

7.58

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$26.90$18.51$10.12Jul 25Dec 25Jul 26
$10.1252-week range$28.26
Loading valuation history…

Fundamentals

Key fundamentals

$1.2B

Market cap

7.9%

Revenue growth (YoY)

52.3%

Gross margin

-$29.7M

Free cash flow (USD)

$151.8M

Net debt

2.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$84.2M$1B

Free cash flow by year

20162025

-$70.1M-$29.7M

Gross margin by year

20212025

53.5%52.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventMay 21, 2026Filing

    Long-Term Incentive Plan Amended

  • 8-K eventMay 15, 2026Filing

    Executive Termination

  • 8-K eventMay 7, 2026Filing

    Earnings Release

  • Quarterly reportMay 7, 2026Filing

    10-Q Filed

Questions

Frequently asked questions

What is Tandem Diabetes Care, Inc.'s market cap?

Tandem Diabetes Care, Inc. (TNDM) has a market capitalization of $1.2B.

What is TNDM's P/E ratio?

A meaningful P/E ratio is not available for TNDM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TNDM's price-to-book (P/B) ratio?

TNDM trades at 7.58 times book value per share.

Are insiders buying TNDM stock?

SEC Form 4 filings show no open-market insider buys at Tandem Diabetes Care, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.